IA
Mediwhale Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Dr. Noon CVD | Cardiovascular disease risk prediction | Regulatory Approved |
| Dr. Noon Fundus | Glaucoma, cataract, and retinal disease diagnosis | Regulatory Approved |
| Retinal AI for CKD | Chronic kidney disease risk assessment | Research/Pre‑clinical |
| Retinal AI for NAFLD | Non‑alcoholic fatty liver disease risk assessment | Research/Pre‑clinical |
| Retinal AI for Neurodegeneration | Early detection of neurodegenerative risk | Research/Pre‑clinical |